MENU
ALVO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alvotech (ALVO) Ownership - Who owns Alvotech?
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more
Profile
Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
2.51B
P/E Ratio
35.09
Total Cash
151.45M
Projected Growth
N/A
Total Debt
1.27B
Revenue
560.1M
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash/Share
0.49
Total Debt/Equity
N/A
Revenue/Share
1.96 USD as % of share price
Fundamentals
ALVO
Capitalization
2.52B
P/E Ratio
35.09
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash
151M
Total Cash/Share
0.49
Total Debt
1.27B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.96%
Revenue
560M
ROE
N/A
Book Value
-173.33M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.92M
Current Ratio
1.82
Current Revenue Per Employee
167867.25
Dividends Per Share - Security
N/A
EBITDA
207M
Float
N/A
Float - Current
N/A
Gross Income Margin
57.39
Revenue To Assets
5.15
Shares Held By Institutions
260M
Shares Outstanding - Current
312M
Total Liabilities
1.57B
Total Volume MTD
N/A
Value
N/A
Gain YTD
-39.002
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALVO showed earnings on August 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsGeneric
Profile
Fundamentals
Details
Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com